https://peptidesciencedaily.com/news/european-commission-approves-oral-wegovy-semaglutide Peptide Science Daily en 2026-07-18T09:00:00Z European Commission Approves Oral Wegovy Pill for Weight Management in the EU https://peptidesciencedaily.com/research/zalfermin-semaglutide-mash-cirrhosis-phase-2-trial Peptide Science Daily en 2026-07-16T09:00:00Z Zalfermin Plus Semaglutide Misses Its Primary Endpoint in Phase 2 Liver Fibrosis Trial